Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR236553 (REGN727) in heterozygous familial hypercholesterolemia with elevated LDL-C
2012-001096-37Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alirocumab in familial hypercholesterolemia (FH), sponsored by Sanofi. Started Jul 2012; status: completed.
02
Drugs
alirocumab
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2012-001096-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001096-37.